SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-004377
Filing Date
2013-09-10
Accepted
2013-09-10 06:00:54
Documents
22
Period of Report
2013-09-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a50705313.htm 8-K 28688
2 EXHIBIT 99.1 a50705313ex99_1.htm EX-99.1 38743
3 SLIDE 1 slide1.jpg GRAPHIC 223045
4 SLIDE 2 slide2.jpg GRAPHIC 524478
5 SLIDE 3 slide3.jpg GRAPHIC 263284
6 SLIDE 4 slide4.jpg GRAPHIC 290921
7 SLIDE 5 slide5.jpg GRAPHIC 283233
8 SLIDE 6 slide6.jpg GRAPHIC 445701
9 SLIDE 7 slide7.jpg GRAPHIC 232966
10 SLIDE 8 slide8.jpg GRAPHIC 227183
11 SLIDE 9 slide9.jpg GRAPHIC 287332
12 SLIDE 10 slide10.jpg GRAPHIC 188822
13 SLIDE 11 slide11.jpg GRAPHIC 228226
14 SLIDE 12 slide12.jpg GRAPHIC 239831
15 SLIDE 13 slide13.jpg GRAPHIC 315589
16 SLIDE 14 slide14.jpg GRAPHIC 173170
17 SLIDE 15 slide15.jpg GRAPHIC 377666
18 SLIDE 16 slide16.jpg GRAPHIC 258230
19 SLIDE 17 slide17.jpg GRAPHIC 227036
20 SLIDE 18 slide18.jpg GRAPHIC 35768
21 SLIDE 19 slide19.jpg GRAPHIC 273945
22 SLIDE 20 slide20.jpg GRAPHIC 281531
  Complete submission text file 0001157523-13-004377.txt   7481222
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 131086810
SIC: 2834 Pharmaceutical Preparations